Soumen Paul

Soumen Paul, Ph.D, currently serves as Study Director at BIOQUAL, Inc., where responsibilities include leading the Imaging Unit, developing imaging protocols, and overseeing the procurement of radioligands for optimal PET-CT performance. Previous experience includes working at the University of Virginia as a Preclinical PET Imaging specialist, managing animal imaging experiments with the Bruker Preclinical Trimodal Albira Scanner. Soumen Paul held a post-doctoral fellowship in PET Neuroimaging at the National Institute of Mental Health, focusing on the pharmacokinetics of a novel PET radioligand and conducting a database project on brain translocator protein imaging. Prior to this, Soumen Paul was a postdoctoral researcher at the University of Manitoba and completed doctoral studies at UMCG.